CN Patent

CN101466392B — 用于预防或治疗hiv感染的药用组合物及其应用

Assigned to Tianjin Fusogen Pharmaceuticals Inc · Expires 2011-10-12 · 15y expired

What this patent protects

本发明涉及用于预防或治疗HIV感染的药用组合物及其应用，更具体地讲，本发明涉及含有抗病毒肽的药用组合物、所述药用组合物用于预防或治疗HIV感染和制备相应的药物的应用，以及使用所述含抗病毒肽的药用组合物预防或治疗HIV感染的方法。

USPTO Abstract

本发明涉及用于预防或治疗HIV感染的药用组合物及其应用，更具体地讲，本发明涉及含有抗病毒肽的药用组合物、所述药用组合物用于预防或治疗HIV感染和制备相应的药物的应用，以及使用所述含抗病毒肽的药用组合物预防或治疗HIV感染的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101466392B
Jurisdiction
CN
Classification
—
Expires
2011-10-12
Drug substance claim
No
Drug product claim
No
Assignee
Tianjin Fusogen Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.